Cargando...
NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse
Acute myeloid leukemia (AML) with NPM1 mutation (NPM1(mut)) defines a World Health Organization entity. Absence of minimal residual disease (MRD) following induction chemotherapy is associated with an excellent prognosis. Data are conflicting on NPM1(mut) AML relapsing with wild-type NPM1 (NPM1(wt))...
Guardado en:
| Publicado en: | Blood Adv |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258925/ https://ncbi.nlm.nih.gov/pubmed/30455361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018023432 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|